Stockreport

Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference [Yahoo! Finance]

Satellos Bioscience Inc.  (MSLE) 
PDF Satellos Bioscience Inc. Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulde [Read more]